NEUROSENSE THERAPEUTICS LTD's ticker is and the CUSIP is M74240116. A total of 6 filers reported holding NEUROSENSE THERAPEUTICS LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,040 | -28.3% | 76,109 | -2.1% | 0.00% | -33.3% |
| Q2 2023 | $15,390 | -49.2% | 77,709 | -0.1% | 0.00% | -50.0% |
| Q1 2023 | $30,266 | +110.5% | 77,765 | -2.4% | 0.01% | +200.0% |
| Q4 2022 | $14,380 | -24.3% | 79,668 | -2.7% | 0.00% | -33.3% |
| Q3 2022 | $19,000 | -51.3% | 81,900 | +6.2% | 0.00% | -66.7% |
| Q2 2022 | $39,000 | +39.3% | 77,100 | +60.7% | 0.01% | – |
| Q1 2022 | $28,000 | -54.1% | 47,992 | -27.9% | 0.00% | -100.0% |
| Q4 2021 | $61,000 | – | 66,606 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 160,000 | $82,000 | 0.44% |
| Warberg Asset Management LLC | 77,100 | $39,000 | 0.01% |
| CLEAR STREET LLC | 52,458 | $27,000 | 0.00% |
| Hudson Bay Capital Management LP | 150,000 | $81,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |